Verrica Pharmaceuticals Inc (VRCA) financials · rev $35.6M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Verrica Pharmaceuticals Inc (VRCA) rev $35.6M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $35.6M | $7.57M |
| Cost of Revenue | N/A | $2.60M |
| Gross Profit | N/A | $4.97M |
| Operating Income | -$12.2M | -$65.9M |
| Net Income | -$17.9M | -$76.6M |
| EPS (Diluted) | -$1.68 | -$1.48 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $47.1M | $54.1M |
| Current Assets | $42.5M | $51.2M |
| Cash & Equivalents | $30.1M | $46.3M |
| Inventory | $2.24M | $2.46M |
| PP&E | $209.0K | $589.0K |
| Total Liabilities | $22.4M | $64.0M |
| Current Liabilities | $16.4M | $29.0M |
| Short-term Debt | N/A | $12.9M |
| Long-term Debt | N/A | $31.0M |
| Total Debt | N/A | $43.9M† |
| Shareholders' Equity | $24.7M | -$9.86M |
| Retained Earnings | -$324.9M | -$307.0M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$17.6M | -$60.9M |
| CapEx | N/A | $27.0K |
| Investing Cash Flow | N/A | -$19.0K |
| Financing Cash Flow | $1.45M | $37.7M |
| Net Change in Cash | -$16.2M | -$23.2M |
| Free Cash Flow | -$17.6M | -$61.0M |
FAQ
What is VRCA P/E and revenue?
Verrica Pharmaceuticals Inc (VRCA) rev $35.6M.
What is VRCA revenue?
Verrica Pharmaceuticals Inc last cached revenue is $35.6M (FY2025).
Is VRCA profitable?
Verrica Pharmaceuticals Inc last cached net income is -$17.9M (FY2025).
What are VRCA total assets?
Verrica Pharmaceuticals Inc last cached total assets are $47.1M (FY2025).
What is VRCA free cash flow?
Verrica Pharmaceuticals Inc last cached free cash flow is -$17.6M (FY2025).
Not investment advice. Cached statements, not a live tape.